InstantScripts (exited July-23)

About

InstantScripts is a digital healthcare platform that enables Australians to conveniently access high quality doctor care and routine prescription medication in a safe, secure and clinically responsible manner.

InstantScripts allows consumers to access doctor-approved routine prescription medication, telehealth consultations and pathology testing from the convenience of their own home via its web and app-based services. These services are all delivered at price points that are attractive for consumers, combined with an added level of convenience.  

Investment exit

In July 2023, InstantScripts was acquired for $135m by Australian Pharmaceutical Industries Pty Ltd (API), a wholly-owned subsidiary of Wesfarmers Limited. BTI’s investment in InstantScripts delivered cash proceeds of $52.1m and an internal rate of return (IRR) of 62%.

Click here for an overview of our investment in InstantScripts.

Offices

Melbourne (HQ), Australia. 

Bailador Investment Team managers

• Paul Wilson (Director)
• James Johnstone